Petra Keikavoussi

Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma

Beatrice Thurner, Ina Haendle, Claudia Röder et al. · The Journal of Experimental Medicine · 1999 · 1.2K citations · Full text

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG

Dirk Schadendorf, Selma Ugurel, Beatrice Schuler‐Thurner et al. · Annals of Oncology · 2006 · 466 citations · Full text

Cancer Immunosurveillance, Medicine, Melanoma +9

Lack of clinical efficacy of imatinib in metastatic melanoma

Selma Ugurel, Ralf Hildenbrand, A Zimpfer et al. · British Journal of Cancer · 2005 · 241 citations · Full text

Mage-3 and Influenza-Matrix Peptide-Specific Cytotoxic T Cells Are Inducible in Terminal Stage HLA-A2.1+ Melanoma Patients by Mature Monocyte-Derived Dendritic Cells

Beatrice Schuler-Thurner, Detlef Dieckmann, Petra Keikavoussi et al. · The Journal of Immunology · 2000 · 202 citations · Full text

Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression

Jens‐Jörg Schnorr, Stavra A. Xanthakos, Petra Keikavoussi et al. · Proceedings of the National Academy of Sciences · 1997 · 179 citations · Full text

Viral Pathogenesis, Immunology, Pathology +19